Logo image of BMGL

BASEL MEDICAL GROUP LTD (BMGL) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BMGL - VGG0864B1031 - Common Stock

0.7669 USD
+0.05 (+6.35%)
Last: 12/11/2025, 12:29:21 PM
Fundamental Rating

4

Taking everything into account, BMGL scores 4 out of 10 in our fundamental rating. BMGL was compared to 100 industry peers in the Health Care Providers & Services industry. BMGL has an average financial health and profitability rating. BMGL has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year BMGL was profitable.
In the past year BMGL has reported a negative cash flow from operations.
BMGL Yearly Net Income VS EBIT VS OCF VS FCFBMGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 1M 2M 3M 4M

1.2 Ratios

BMGL has a better Return On Assets (11.76%) than 95.00% of its industry peers.
The Return On Equity of BMGL (24.18%) is better than 91.00% of its industry peers.
The Return On Invested Capital of BMGL (36.92%) is better than 99.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BMGL is significantly above the industry average of 9.44%.
The 3 year average ROIC (29.84%) for BMGL is below the current ROIC(36.92%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.76%
ROE 24.18%
ROIC 36.92%
ROA(3y)12.01%
ROA(5y)N/A
ROE(3y)37.76%
ROE(5y)N/A
ROIC(3y)29.84%
ROIC(5y)N/A
BMGL Yearly ROA, ROE, ROICBMGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 10 20 30 40 50

1.3 Margins

BMGL's Profit Margin of 11.64% is amongst the best of the industry. BMGL outperforms 97.00% of its industry peers.
The Operating Margin of BMGL (32.46%) is better than 98.00% of its industry peers.
Industry RankSector Rank
OM 32.46%
PM (TTM) 11.64%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMGL Yearly Profit, Operating, Gross MarginsBMGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

BMGL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for BMGL remains at a similar level compared to 1 year ago.
BMGL has a better debt/assets ratio than last year.
BMGL Yearly Shares OutstandingBMGL Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M
BMGL Yearly Total Debt VS Total AssetsBMGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M

2.2 Solvency

BMGL has an Altman-Z score of 2.40. This is not the best score and indicates that BMGL is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.40, BMGL is in line with its industry, outperforming 54.00% of the companies in the same industry.
A Debt/Equity ratio of 0.55 indicates that BMGL is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.55, BMGL is in the better half of the industry, outperforming 62.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z 2.4
ROIC/WACC4.59
WACC8.04%
BMGL Yearly LT Debt VS Equity VS FCFBMGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2M 4M 6M

2.3 Liquidity

A Current Ratio of 1.88 indicates that BMGL should not have too much problems paying its short term obligations.
BMGL has a Current ratio of 1.88. This is in the better half of the industry: BMGL outperforms 78.00% of its industry peers.
A Quick Ratio of 1.87 indicates that BMGL should not have too much problems paying its short term obligations.
BMGL's Quick ratio of 1.87 is fine compared to the rest of the industry. BMGL outperforms 78.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.87
BMGL Yearly Current Assets VS Current LiabilitesBMGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BMGL have decreased strongly by -44.68% in the last year.
The Revenue has been growing slightly by 1.99% in the past year.
EPS 1Y (TTM)-44.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-123.92%
Revenue 1Y (TTM)1.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMGL Yearly Revenue VS EstimatesBMGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.96, which indicates a very decent valuation of BMGL.
90.00% of the companies in the same industry are more expensive than BMGL, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.59. BMGL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.96
Fwd PE N/A
BMGL Price Earnings VS Forward Price EarningsBMGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BMGL is valued cheaper than 99.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.67
BMGL Per share dataBMGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

BMGL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BMGL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BASEL MEDICAL GROUP LTD

NASDAQ:BMGL (12/11/2025, 12:29:21 PM)

0.7669

+0.05 (+6.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.7%
Inst Owner ChangeN/A
Ins Owners13.65%
Ins Owner ChangeN/A
Market Cap14.41M
Revenue(TTM)15.09M
Net Income(TTM)1.76M
AnalystsN/A
Price TargetN/A
Short Float %2.47%
Short Ratio2.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.96
Fwd PE N/A
P/S 1.24
P/FCF N/A
P/OCF N/A
P/B 2.57
P/tB 2.57
EV/EBITDA 0.67
EPS(TTM)0.07
EY9.13%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.62
BVpS0.3
TBVpS0.3
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.69
Profitability
Industry RankSector Rank
ROA 11.76%
ROE 24.18%
ROCE 67.42%
ROIC 36.92%
ROICexc 1026.25%
ROICexgc 1026.25%
OM 32.46%
PM (TTM) 11.64%
GM N/A
FCFM N/A
ROA(3y)12.01%
ROA(5y)N/A
ROE(3y)37.76%
ROE(5y)N/A
ROIC(3y)29.84%
ROIC(5y)N/A
ROICexc(3y)34.59%
ROICexc(5y)N/A
ROICexgc(3y)34.59%
ROICexgc(5y)N/A
ROCE(3y)47.14%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA 0.73
Cap/Depr 2.99%
Cap/Sales 0.12%
Interest Coverage 27.55
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.87
Altman-Z 2.4
F-Score3
WACC8.04%
ROIC/WACC4.59
Cap/Depr(3y)5.99%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.32%
Cap/Sales(5y)N/A
Profit Quality(3y)134.28%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-123.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.49%
OCF growth 3YN/A
OCF growth 5YN/A

BASEL MEDICAL GROUP LTD / BMGL FAQ

What is the fundamental rating for BMGL stock?

ChartMill assigns a fundamental rating of 4 / 10 to BMGL.


What is the valuation status of BASEL MEDICAL GROUP LTD (BMGL) stock?

ChartMill assigns a valuation rating of 4 / 10 to BASEL MEDICAL GROUP LTD (BMGL). This can be considered as Fairly Valued.


How profitable is BASEL MEDICAL GROUP LTD (BMGL) stock?

BASEL MEDICAL GROUP LTD (BMGL) has a profitability rating of 6 / 10.


What are the PE and PB ratios of BASEL MEDICAL GROUP LTD (BMGL) stock?

The Price/Earnings (PE) ratio for BASEL MEDICAL GROUP LTD (BMGL) is 10.96 and the Price/Book (PB) ratio is 2.57.